Navigation Links and a Portfolio of 318 'Genetic' Domain Names to be Auctioned Off at Domain Development Conference

SEATTLE, Sept. 14 /PRNewswire/ --, a leading domain name development company, will release a list of DNA and Genetic developed domain names to be auctioned off on September 16, at 1:30 pm at the Bell Harbor Conference Center Bay Auditorium in Seattle. The domain auction is part of the inaugural Domain Developers Conference being held September 15 – 17.  The live auction event is open to the public.

The auction lot contains the premium domain name and website, as well as an additional 318 DNA and genetics-related informational domain names. Scientists believe DNA sequencing will revolutionize preventative medicine, as knowing the genetic blueprints of an individual will reveal predispositions for specific conditions and diseases such as cancer, diabetes, addiction, etc and lead to 'personalized medicine'.

"Owning a massive amount of Internet Real Estate associated with DNA Sequencing, genetic mapping and personalized medicine can be a windfall for a biotechnology company that wants to control the space and capture the associated Internet search traffic," says Rob Monster, Chairman and CEO of "Companies like Illumina, Complete Genomics, Pacific Biosystems, IBM, Agilent, Alpha Biolab, Ambrygen, Biobasic, Elimbio, Genewiz, Genscript, Ion Torrent, Mpbio, Laragen, Sequenom, Sequetech, Seqwright, etc. could effectively control the marketplace overnight by owning these domains," said Monster.

The auction lot will feature such domains as,,,,,,,,,, and more.

Interested parties can participate in the live auction in-person or online through a real-time Internet interface. Those wanting to submit a proxy bid for the domain and website auction can contact directly for more information and instructions. The auction is managed by Moniker® ( and SnapNames® (, both® companies and providers of domain name registration, management, monetization, and brokerage services. Bidders can follow the auction live and, bid online or in person. Conference details can be found at:

About was founded in 2009 with a simple goal – to help domain investors evolve from a singular dependence on domain parking to a more diversified array of value creation strategies that unlock the potential associated with an intuitive domain name. is based in Seattle and is a leading provider of managed solutions for domain investing serving the needs of individuals and institutions that seek exposure to the domain name asset class.

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shire Proposes to Expand Specialist Gastrointestinal Portfolio
2. MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio
3. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems
6. Mendel Announces US Miscanthus Field Trial Results: Second Year Data Demonstrate High-Yielding, Genetically Diverse Product Portfolio
7. Shires Replenished Portfolio Drives Excellent Quarterly Performance
8. Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
9. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
10. EUCODIS Bioscience Receives EUR 2 Million Cash Injection to Enlarge Product Portfolio and Develop International Markets
11. New Industry Research Identifies "Operational Gap" in Clinical Trial Portfolio Management
Post Your Comments:
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... be speaking at the following conference, and invited investors ... York, NY      Tuesday, December 1, 2015 at ... York, NY      Tuesday, December 1, 2015 at ... Healthcare Conference, New York, NY ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - Aeterna ... request of IIROC on behalf of the Toronto Stock ... news release there are no corporate developments that would ... --> --> About ... . --> Aeterna Zentaris is ...
Breaking Biology Technology:
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
(Date:10/29/2015)... , Oct. 29, 2015 Today, ... a partnership with 2XU, a global leader in ... a smart hat with advanced bio-sensing technology. The ... athletes to monitor key biometrics to improve overall ... partnership, the two companies will bring together the most ...
(Date:10/27/2015)... Oct. 27, 2015 Synaptics Inc. (NASDAQ: SYNA ... that Google has adopted the Synaptics ® ClearPad ... to power its newest flagship smartphones, the Nexus 5X ... --> --> Synaptics ... provide strategic collaboration in the joint development of next ...
Breaking Biology News(10 mins):